Format

Send to

Choose Destination
Kidney Int Rep. 2018 Mar 17;3(4):889-896. doi: 10.1016/j.ekir.2018.03.008. eCollection 2018 Jul.

Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study.

Author information

1
Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
2
Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
3
Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
4
Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
5
Department of Nephrology, People's Hospital, School of Medicine, Peking University, Beijing, China.
6
Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
7
Peking University First Hospital, Beijing, China Institute of Nephrology, Peking University, Beijing, China.
8
Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.

Abstract

Introduction:

In China, a quarter of patients are undergoing 2-times weekly hemodialysis. Using data from the China Dialysis Outcomes and Practice Patterns Study (DOPPS), we tested the hypothesis that whereas survival and hospitalizations would be similar in the presence of residual kidney function (RKF), patients without RKF would fare worse on 2-times weekly hemodialysis.

Methods:

In our cohort derived from 15 units randomly selected from each of 3 major cities (total N = 45), we generated a propensity score for the probability of dialysis frequency assignment, estimated a survival function by propensity score quintiles, and averaged stratum-specific survival functions to generate mean survival time. We used the proportional rates model to assess hospitalizations. We stratified all analyses by RKF, as reported by patients (urine output <1 vs. ≥1 cup/day).

Results:

Among 1265 patients, 123 and 133 were undergoing 2-times weekly hemodialysis with and without evidence of RKF. Over 2.5 years, adjusted mean survival times were similar for 2- versus 3-times weekly dialysis groups: 2.20 versus 2.23 and 2.20 versus 2.15 for patients with and without RKF (P = 0.65). Hazard ratios for hospitalization rates were similar for 2- versus 3-times weekly groups, with (1.15, 95% confidence interval = 0.66-2.00) and without (1.10, 95% confidence interval 0.68-1.79]) RKF. The normalized protein catabolic rate was lower and intradialytic weight gain was not substantially higher in the 2- versus 3-times weekly dialysis group, suggesting greater restriction of dietary sodium and protein.

Conclusion:

In our study of patients in China's major cities, we could not detect differences in survival and hospitalization for those undergoing 2- versus 3-times weekly dialysis, regardless of RKF. Our findings indicate the need for pragmatic studies regarding less frequent dialysis with associated nutritional management.

KEYWORDS:

2-times weekly hemodialysis; dialysis frequency; dialysis provision in low-resource settings; outcomes on hemodialysis

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center